PULMONARY EMBOLISM

Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis

J-C Lega^1,2, Y Lacasse¹, L Lakhal^1,3, S Provencher¹

¹ Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec (Hôpital Laval), Québec, Canada
² Service de médecine interne et de pathologie vasculaire, Centre Hospitalier Lyon Sud, Université Claude Bernard Lyon 1, Lyon, France
³ Département de mathématiques et statistique, Université Laval, Québec, Canada

^{Correspondence to} Dr S Provencher, Centre de Pneumologie, Hôpital Laval, 2725 Chemin Ste-Foy, Québec, P Québec, G1V 4G5 Canada; steve.provencher{at}crhl.ulaval.ca

Background: The role of biomarkers such as B-type natriuretic peptides (BNP and NT-proBNP) and troponins in risk stratification of acute pulmonary embolism (APE) is still debated. A meta-analysis was performed to assess the association between raised natriuretic peptide levels, alone or in conjunction with troponins, and all-cause and APE-related mortality, serious adverse events and echographic right ventricular dysfunction.

Methods: MEDLINE and EMBASE databases were searched and conference abstracts were hand searched up to February 2008. Studies were included if a 2x2 table could be constructed based on natriuretic peptide results and at least one of the outcomes.

Results: Twenty-three studies were included (1127 patients). Raised natriuretic peptide levels were significantly associated with all-cause mortality (odds ratio (OR) 6.2; 95% confidence interval (CI) 3.0 to 12.7), APE-related mortality (OR 5.0; 95% CI 2.2 to 11.5) and serious adverse events (OR 6.7; 95% CI 3.9 to 11.6), with homogeneity across studies. Among patients with raised natriuretic peptide levels, increased serum troponins were associated with a further increase in the risk of adverse outcomes. Analysis of the accuracy of natriuretic peptides in detecting right ventricular dysfunction was limited by heterogeneity across studies. BNP appeared to have better sensitivity and specificity than NT-proBNP in detecting right ventricular dysfunction.

Conclusions: Raised levels of B-type natriuretic peptides identified a subset of patients with APE at higher risk of adverse outcomes. Among patients with raised natriuretic peptide levels, increased troponins were found to be an independent prognostic marker. The results of this meta-analysis may have important clinical implications in the management of APE.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Identification of those at risk after acute pulmonary embolism

Andrew J Fisher and Paul A Corris
Thorax 2009 64: 832-833. [Extract] [Full Text] [PDF]

Airwaves

Wisia Wedzicha
Thorax 2009 64: i. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Fisher, A. J, Corris, P. A (2009). Identification of those at risk after acute pulmonary embolism. Thorax 64: 832-833 [Full Text]